Professor, Medicine, New York Med Coll
Oncology
Dr. Michael P. Fanucchi, MD
|
|
Give Review
Dr. Michael P. Fanucchi practices Oncology. He went to medical school at Columbia University College of Physicians & Surgeons. Columbia University College of Physicians & Surgeons is a one of the best medicals schools. Columbia University College of Physicians & Surgeons is ranked 8/52 in Research/PrimaryCare. Doctor Michael P. Fanucchi, MD has written publications. He has 24 publications published with PubMed. The lastest publication is: 'Reversible Epstein-Barr virus associated T cell non-Hodgkin''s lymphoma in a patient with rheumatoid arthritis undergoing chronic immunosuppressive therapy.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- A phase 1 Bayesian dose selection study of bortezomib and sunitinib in patients with refractory solid tumor malignancies.
- Farnesyl transferase expression determines clinical response to the docetaxel-lonafarnib combination in patients with advanced malignancies.
- Phase I combination study of trabectedin and doxorubicin in patients with soft-tissue sarcoma.
- Randomized phase II study of bortezomib alone and bortezomib in combination with docetaxel in previously treated advanced non-small-cell lung Cancer.
- Selective serotonin reuptake inhibitor-induced rhabdomyolysis associated with irinotecan.
- 2'-Fluoro-5-iodoarabinosylcytosine, a new potent antiviral agent: efficacy in immunosuppressed individuals with herpes zoster.
- Reversible Epstein-Barr virus associated T cell non-Hodgkin''s lymphoma in a patient with rheumatoid arthritis undergoing Chronic immunosuppressive therapy.
- Clinical pharmacology and metabolism of trimetrexate.
- Incorporation and metabolism of 2''-fluoro-5-substituted arabinosyl pyrimidines and their selective inhibition of viral DNA synthesis in herpes simplex virus type 1 (H...
- Cell differentiation effects of 2''-fluoro-1-beta-D-arabinofuranosyl pyrimidines in HL-60 cells.
- Antagonistic interactions of hexamethylene bisacetamide in combination with 1-beta-D-arabinofuranosylcytosine, adriamycin and harringtonine on the growth and different...
- Phase I trial of 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU).
- Phase I trial and clinical pharmacological evaluation of 10-ethyl-10-deazaaminopterin in adult patients with advanced Cancer.
- Update on the management of connective tissue malignancies.
- Phase I and clinical pharmacology study of trimetrexate administered weekly for three weeks.
- Hypoglycemia in the setting of advanced gastrointestinal stromal tumor.
- Clear cell carcinoma of the ovary: a remarkable case.
- Chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.
- Phase II trial of trimetrexate in patients with stage III and IV non-small-cell lung Cancer.
- Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung Cancer.
- Taxanes in the treatment of non-small cell lung Cancer.
- Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance fo...
- Recent advances of novel targeted therapy in non-small cell lung Cancer.
Schools
Columbia University College Of Physicians and Surgeons
Bronx Muni Hospital Center
Meml Sloan Kettering Canc C
Conditions Treated
- Anal and Rectal Cancer
- Anemia
- Bile Duct Cancer
- Bladder Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
Memorial Sloan-Kettering Cancer Center -
Albert Einstein College of Medicine at Jacobi Medical Center -
Columbia University College of Physicians & Surgeons
Drug Facts
| NPI NUMBER | 1043327620 | |
| NPPES Provider LastName | FANUCCHI | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 105236007 | |
| NPPES Provider State | NY | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 96.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1043327620 |
| Last Name Of The Provider | FANUCCHI |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
|
Dr. William S. Jonas, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John W. Eley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bradley C. Carthon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vamsi K. Kota, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wendy M. Baer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erin M. Dunbar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bamidele A. Adesunloye, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Margaret K. Offermann, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Mamoru Shoji, MD
This Doctor is OpenDoctor Recommended.
|